Showing 701-710 of 2322 results for "".
Pharma Sales 2.0
https://practicaldermatology.com/topics/practice-management/pharma-sales-20/23959/A behind-the-scenes look at how ReachRX aims to transform pharma sales and boost patient access.DataDerm Update
https://practicaldermatology.com/topics/practice-management/dataderm-update/23891/Joining can do a lot for your practice and patients.Cognitive Bias And The Art of Doctoring
https://practicaldermatology.com/topics/practice-management/cognitive-bias-and-the-art-of-doctoring/23680/Rethinking the approach to diagnosis may reduce errors and improve patient interactions.Inclusivity: A Concerted Effort
https://practicaldermatology.com/series/diversity-and-equity-in-dermatology/inclusivity-a-concerted-effort/19915/Historical events and recent developments contribute to some patients’ skepticism of medicine in general and dermatology specifically. Hear what panelists say about the best approaches to expand inclusivity in research, clinical trials, and patient care. It will take a concerted effort to overcome cUp the Authenticity Factor on Your Dermatology Social Media
https://practicaldermatology.com/topics/practice-management/up-the-authenticity-factor-on-your-dermatology-social-media/23423/Strike the right tone and find the balance needed to truly engage with your current and potential patients.Buyer Beware: CBD Products May Peddle False Hope Amid Corona Fears
https://practicaldermatology.com/series/dermatology-dispatches/buyer-beware-cbd-products-may-peddle-false-hope-amid-corona-fears/19775/Any claims that a medical cannabinoid-based product can kill COVID-19 are “absolutely unsubstantiated,” warns Adam Friedman, MD. There is no evidence that these products contain any antiviral properties, and patients should be advised against believing such claims.COVID-19 Impact: iPledge and Isotretinoin Prescribing
https://practicaldermatology.com/topics/acne-rosacea/covid-19-impact-ipledge-and-isotretinoin-prescribing/19763/For patients on isotretinoin, complying with the iPledge program while treating patients virtually can be challenging. Joshua Zeichner, MD discusses new FDA guidance that allows female patients to take OTC pregnancy tests in order to continue treatment. He also discusses when patients do and do notLight & Bright: A new treatment to illuminate your practice
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/light-bright-a-new-treatment-to-illuminate-your-practice/19746/Join Matthew Mahlberg, MD as he introduces the new Light & Bright treatment. Using the patented Ellipse IPL and Frax 1550 technologies on the Nordlys system, the Light & Bright treatment reduces pigmentation & redness and improves textural irregularities. Hear the results of a clinical sBusting Pediatric Dermatology Myths
https://practicaldermatology.com/topics/pediatric/busting-pediatric-dermatology-myths/23078/Do you know what your patients think they know about skin diseases?Utilize User Generated Content for your Dermatology Practice
https://practicaldermatology.com/topics/practice-management/utilize-user-generated-content-for-your-dermatology-practice/20457/When patients participate in content creation, engagement may increase.